AU2002218220A1 - Method for producing powdery formulations - Google Patents
Method for producing powdery formulationsInfo
- Publication number
- AU2002218220A1 AU2002218220A1 AU2002218220A AU2002218220A AU2002218220A1 AU 2002218220 A1 AU2002218220 A1 AU 2002218220A1 AU 2002218220 A AU2002218220 A AU 2002218220A AU 2002218220 A AU2002218220 A AU 2002218220A AU 2002218220 A1 AU2002218220 A1 AU 2002218220A1
- Authority
- AU
- Australia
- Prior art keywords
- producing powdery
- powdery formulations
- formulations
- producing
- powdery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10050635.6 | 2000-10-12 | ||
DE10050635 | 2000-10-12 | ||
DE2001138022 DE10138022A1 (en) | 2001-08-10 | 2001-08-10 | Production of homogeneous inhalation powders comprises introducing alternate layers of large excipient particles and small drug particles into a mixing vessel |
DE10138022.4 | 2001-08-10 | ||
PCT/EP2001/011636 WO2002030390A2 (en) | 2000-10-12 | 2001-10-09 | Method for producing powdery formulations |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002218220A1 true AU2002218220A1 (en) | 2002-06-27 |
AU2002218220B2 AU2002218220B2 (en) | 2006-06-15 |
Family
ID=26007343
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002218220A Expired AU2002218220B2 (en) | 2000-10-12 | 2001-10-09 | Method for producing powdery formulations |
AU1822002A Pending AU1822002A (en) | 2000-10-12 | 2001-10-09 | Method for producing powdery formulations |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU1822002A Pending AU1822002A (en) | 2000-10-12 | 2001-10-09 | Method for producing powdery formulations |
Country Status (40)
Country | Link |
---|---|
US (2) | US6585959B2 (en) |
EP (1) | EP1326585B2 (en) |
JP (2) | JP4986369B2 (en) |
KR (1) | KR100849837B1 (en) |
CN (1) | CN1269470C (en) |
AR (1) | AR034166A1 (en) |
AT (1) | ATE319422T1 (en) |
AU (2) | AU2002218220B2 (en) |
BG (1) | BG66194B1 (en) |
BR (1) | BR0114316A (en) |
CA (1) | CA2425005C (en) |
CY (1) | CY1105037T1 (en) |
CZ (1) | CZ300022B6 (en) |
DE (1) | DE50109178D1 (en) |
DK (1) | DK1326585T4 (en) |
EA (1) | EA004689B1 (en) |
EE (1) | EE05146B1 (en) |
EG (1) | EG24478A (en) |
ES (1) | ES2259046T5 (en) |
HK (1) | HK1060522A1 (en) |
HR (1) | HRP20030277B1 (en) |
HU (1) | HU229512B1 (en) |
IL (2) | IL154919A0 (en) |
ME (1) | ME02762B (en) |
MX (1) | MXPA03003219A (en) |
MY (1) | MY155912A (en) |
NO (1) | NO333719B1 (en) |
NZ (1) | NZ525781A (en) |
PE (1) | PE20020424A1 (en) |
PL (1) | PL204733B1 (en) |
PT (1) | PT1326585E (en) |
RS (1) | RS50495B (en) |
SA (1) | SA01220518B1 (en) |
SI (1) | SI1326585T2 (en) |
SK (1) | SK285841B6 (en) |
TW (1) | TWI283180B (en) |
UA (1) | UA75375C2 (en) |
UY (1) | UY26960A1 (en) |
WO (1) | WO2002030390A2 (en) |
ZA (1) | ZA200301349B (en) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1292281B1 (en) * | 2000-10-12 | 2004-09-08 | Boehringer Ingelheim Pharma GmbH & Co.KG | Novel tiotropium-containing inhalation powder |
US6443152B1 (en) * | 2001-01-12 | 2002-09-03 | Becton Dickinson And Company | Medicament respiratory delivery device |
EP1397134A2 (en) * | 2001-05-25 | 2004-03-17 | Boehringer Ingelheim Pharma GmbH & Co.KG | Combination of a dopamine d2-receptor agonist and tiotropium or a derivative therof for treating obstructive airways |
US20030070679A1 (en) * | 2001-06-01 | 2003-04-17 | Boehringer Ingelheim Pharma Kg | Capsules containing inhalable tiotropium |
US20030008001A1 (en) * | 2001-06-13 | 2003-01-09 | Boehringer Ingelheim Pharma Kg | Process for cleaning hard gelatine capsules |
US20030018019A1 (en) * | 2001-06-23 | 2003-01-23 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics |
DE10141377A1 (en) * | 2001-08-23 | 2003-03-13 | Boehringer Ingelheim Pharma | Scattering process for the production of powder formulations |
DE10141376A1 (en) * | 2001-08-23 | 2003-03-13 | Boehringer Ingelheim Pharma | Process for the preparation of inhalable powders |
US7309707B2 (en) * | 2002-03-20 | 2007-12-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament |
US7244415B2 (en) * | 2002-03-28 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations of an anhydrate |
NZ536277A (en) * | 2002-04-04 | 2006-03-31 | Boehringer Ingelheim Pharma | Powder formulations containing tiotropium suitable for inhalation |
GB0219513D0 (en) | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Inhalation compositions including coarse carrier |
US20050158248A1 (en) * | 2002-08-21 | 2005-07-21 | Xian-Ming Zeng | Method of preparing dry powder inhalation compositions |
JP4744876B2 (en) * | 2002-08-21 | 2011-08-10 | ノートン・ヘルスケアー リミテッド | Method for producing a dry powder inhalation composition |
GB0219511D0 (en) * | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Method of preparing dry powder inhalation compositions |
EP1599209B1 (en) * | 2002-08-21 | 2011-08-17 | Norton Healthcare Limited | Inhalation composition |
DE10255387A1 (en) * | 2002-11-28 | 2004-06-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New tiotropium-containing powder formulation for inhalation |
US7763280B2 (en) | 2002-11-28 | 2010-07-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tiotropium containing powder formulation for inhalation |
DE10351663A1 (en) * | 2002-12-20 | 2004-07-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Stable, accurately dosable inhalable powder medicament for treating asthma or chronic obstructive pulmonary disease, containing tiotropium, specific form of salmeterol xinafoate and auxiliary |
DE10317461A1 (en) | 2003-04-16 | 2004-10-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Preparing microparticles labeled with technetium, useful as powders for inhalation, e.g. to study deposition of pharmaceuticals, such as anticholinergic agents, involves incubation with solution of technetium salt |
US20040226556A1 (en) | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
US7462367B2 (en) | 2003-07-11 | 2008-12-09 | Boehringer Ingelheim International Gmbh | Anticholinergic powder formulations for inhalation |
DE10331350A1 (en) * | 2003-07-11 | 2005-01-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalation powder useful for treating respiratory diseases comprises a 9,9-dimethyl-7-(2,2-diphenylpropionyloxy)-3-oxa-9-azatricyclononane salt and a finely divided excipient |
US9345664B2 (en) | 2003-09-02 | 2016-05-24 | Norton Healthcare Ltd | Process for preparing a medicament |
GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
EP2083007B1 (en) | 2003-11-03 | 2013-04-24 | Boehringer Ingelheim International Gmbh | Tiotropium salts, method for creating same and medicinal formulations containing same |
SI1682541T1 (en) | 2003-11-03 | 2010-06-30 | Boehringer Ingelheim Int | Method for producing tiotropium salts |
BRPI0417097A (en) * | 2003-12-03 | 2007-03-13 | Microdrug Ag | pre-metered dry powder inhaler for moisture sensitive medicines |
DE102004048389A1 (en) | 2004-10-01 | 2006-04-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Modification of surfaces of lactose as adjuvant for use with powder inhalants |
RU2007133547A (en) | 2005-02-10 | 2009-03-20 | Глаксо Груп Лимитед (GB) | METHODS FOR PRODUCING LACTOSES USING PRELIMINARY SORTING METHODS AND PHARMACEUTICAL COMPOSITIONS PRODUCED FROM IT |
GB0507835D0 (en) * | 2005-04-18 | 2005-05-25 | Solexa Ltd | Method and device for nucleic acid sequencing using a planar wave guide |
SI1881980T1 (en) | 2005-05-02 | 2012-12-31 | Boehringer Ingelheim International Gmbh | Novel crystalline forms of tiotropium bromide |
DE102005059602A1 (en) | 2005-12-14 | 2007-06-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Micronization process |
ES2569359T3 (en) | 2007-07-06 | 2016-05-10 | Vectura Delivery Devices Limited | Inhaler |
EP2264042B1 (en) * | 2007-07-27 | 2012-07-18 | Cargill, Incorporated | Micronization of polyols |
EP2082768A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
EP2082766A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Blister Strip Coil Forming |
EP2082771A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
EP2082767A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
EP2082772A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
EP2662116B1 (en) | 2008-05-09 | 2022-09-21 | Nuvaira, Inc. | Systems and assemblies for treating a bronchial tree |
CN102119238B (en) * | 2008-07-24 | 2014-05-28 | 乔治洛德方法研究和开发液化空气有限公司 | Heteroleptic cyclopentadienyl transition metal precursors for deposition of transition metal-containing films |
TWI491416B (en) | 2008-12-24 | 2015-07-11 | Daiichi Sankyo Co Ltd | A dry powder pharmaceutical composition for inhalation |
GB0918450D0 (en) | 2009-10-21 | 2009-12-09 | Innovata Ltd | Composition |
CN112089394A (en) | 2009-10-27 | 2020-12-18 | 努瓦拉公司 | Delivery device with coolable energy emitting assembly |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
WO2011060200A1 (en) | 2009-11-11 | 2011-05-19 | Innovative Pulmonary Solutions, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
EP2575786B1 (en) | 2010-06-03 | 2017-11-15 | Sima Patent ve Lisanslama Hizmetleri Ltd.Sti. | Process for dry powder formulations |
TR201007251A2 (en) * | 2010-09-01 | 2012-03-21 | Bi̇lgi̇ç Mahmut | Calcium channel blocker formulation. |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
WO2016005443A1 (en) | 2014-07-09 | 2016-01-14 | Arven Ilac Sanayi Ve Ticaret A.S. | A process for the preparation of formulations for inhalation |
ES2776208T3 (en) | 2015-12-03 | 2020-07-29 | Tiefenbacher Alfred E Gmbh & Co Kg | Dry powder mixing procedure |
EP3826620A4 (en) * | 2018-07-12 | 2023-03-08 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Inhalation compositions comprising dopamine agonists |
WO2022146255A1 (en) * | 2020-12-31 | 2022-07-07 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | A process for the preparation of dry powder compositions for inhalation |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1242211A (en) | 1967-08-08 | 1971-08-11 | Fisons Pharmaceuticals Ltd | Pharmaceutical composition |
US3957965A (en) | 1967-08-08 | 1976-05-18 | Fisons Limited | Sodium chromoglycate inhalation medicament |
US3860618A (en) | 1967-08-08 | 1975-01-14 | Philip Saxton Hartley | Chromone |
BE891013A (en) † | 1980-11-05 | 1982-05-05 | Fisons Ltd | PHARMACEUTICAL COMPOSITIONS |
JPS60150823A (en) * | 1984-01-17 | 1985-08-08 | Satake Eng Co Ltd | Grain mixing apparatus |
JPH0439388A (en) * | 1990-06-04 | 1992-02-10 | Teijin Ltd | Method for mixing earth and sand with fibrous material |
DE4140689B4 (en) * | 1991-12-10 | 2007-11-22 | Boehringer Ingelheim Kg | Inhalable powders and process for their preparation |
JPH06198156A (en) * | 1993-01-06 | 1994-07-19 | Nagasaki Pref Gov | Atomizing and laminating mixer |
IS1796B (en) * | 1993-06-24 | 2001-12-31 | Ab Astra | Inhaled polypeptide formulation composition which also contains an enhancer compound |
GB9322014D0 (en) | 1993-10-26 | 1993-12-15 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
GB9404945D0 (en) | 1994-03-15 | 1994-04-27 | Glaxo Group Ltd | Pharmaceutical composition |
DE4425255A1 (en) * | 1994-07-16 | 1996-01-18 | Asta Medica Ag | Formulation for inhalation application |
CA2347856C (en) * | 1998-11-13 | 2009-02-17 | Jago Research Ag | Dry powder for inhalation |
GB9902689D0 (en) | 1999-02-08 | 1999-03-31 | Novartis Ag | Organic compounds |
-
2001
- 2001-09-10 UA UA2003054184A patent/UA75375C2/en unknown
- 2001-10-09 DE DE50109178T patent/DE50109178D1/en not_active Expired - Lifetime
- 2001-10-09 HU HU0301268A patent/HU229512B1/en unknown
- 2001-10-09 EP EP01986599A patent/EP1326585B2/en not_active Expired - Lifetime
- 2001-10-09 SK SK437-2003A patent/SK285841B6/en not_active IP Right Cessation
- 2001-10-09 DK DK01986599.7T patent/DK1326585T4/en active
- 2001-10-09 JP JP2002533833A patent/JP4986369B2/en not_active Expired - Lifetime
- 2001-10-09 AT AT01986599T patent/ATE319422T1/en active
- 2001-10-09 TW TW090124981A patent/TWI283180B/en not_active IP Right Cessation
- 2001-10-09 RS YUP-274/03A patent/RS50495B/en unknown
- 2001-10-09 ES ES01986599T patent/ES2259046T5/en not_active Expired - Lifetime
- 2001-10-09 EE EEP200300170A patent/EE05146B1/en unknown
- 2001-10-09 EA EA200300429A patent/EA004689B1/en not_active IP Right Cessation
- 2001-10-09 ME MEP-2008-427A patent/ME02762B/en unknown
- 2001-10-09 CN CNB01817146XA patent/CN1269470C/en not_active Expired - Lifetime
- 2001-10-09 WO PCT/EP2001/011636 patent/WO2002030390A2/en active IP Right Grant
- 2001-10-09 MX MXPA03003219A patent/MXPA03003219A/en active IP Right Grant
- 2001-10-09 AU AU2002218220A patent/AU2002218220B2/en not_active Expired
- 2001-10-09 PL PL362511A patent/PL204733B1/en unknown
- 2001-10-09 KR KR1020037005039A patent/KR100849837B1/en active IP Right Grant
- 2001-10-09 IL IL15491901A patent/IL154919A0/en active IP Right Grant
- 2001-10-09 AU AU1822002A patent/AU1822002A/en active Pending
- 2001-10-09 SI SI200130509T patent/SI1326585T2/en unknown
- 2001-10-09 CZ CZ20031024A patent/CZ300022B6/en not_active IP Right Cessation
- 2001-10-09 CA CA 2425005 patent/CA2425005C/en not_active Expired - Lifetime
- 2001-10-09 BR BR0114316-6A patent/BR0114316A/en active Pending
- 2001-10-09 PT PT01986599T patent/PT1326585E/en unknown
- 2001-10-09 NZ NZ525781A patent/NZ525781A/en not_active IP Right Cessation
- 2001-10-10 PE PE2001001002A patent/PE20020424A1/en active IP Right Grant
- 2001-10-10 UY UY26960A patent/UY26960A1/en not_active IP Right Cessation
- 2001-10-10 MY MYPI20014704A patent/MY155912A/en unknown
- 2001-10-10 EG EG2001101063A patent/EG24478A/en active
- 2001-10-11 US US09/977,911 patent/US6585959B2/en not_active Ceased
- 2001-10-12 AR ARP010104784A patent/AR034166A1/en active Pending
- 2001-11-11 SA SA01220518A patent/SA01220518B1/en unknown
-
2003
- 2003-02-19 ZA ZA2003/01349A patent/ZA200301349B/en unknown
- 2003-03-13 IL IL154919A patent/IL154919A/en unknown
- 2003-03-26 BG BG107673A patent/BG66194B1/en active Active
- 2003-04-10 HR HR20030277A patent/HRP20030277B1/en not_active IP Right Cessation
- 2003-04-11 NO NO20031692A patent/NO333719B1/en not_active IP Right Cessation
-
2004
- 2004-01-28 US US10/766,748 patent/USRE38912E1/en not_active Expired - Lifetime
- 2004-05-20 HK HK04103581A patent/HK1060522A1/en not_active IP Right Cessation
-
2006
- 2006-05-19 CY CY20061100654T patent/CY1105037T1/en unknown
-
2009
- 2009-06-08 JP JP2009136927A patent/JP2009197025A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002218220A1 (en) | Method for producing powdery formulations | |
HK1060522A1 (en) | Method for producing powdery formulations | |
AU2002224154A1 (en) | Method for producing polybutene | |
AU2001240115A1 (en) | Method for the preparation of tetrahydrobenzothiepines | |
AU2001263004A1 (en) | System for continuously producing gum | |
AU2002213972A1 (en) | Method for producing polyisobutenylphenoles | |
AU2001239243A1 (en) | Method for producing nanosuspensions | |
AU2001233699A1 (en) | Method for selecting products | |
AU2001291313A1 (en) | Process for making 3-amino-2-chloro-4-methylpyridine | |
AU2001274958A1 (en) | Filling method | |
EP1298117A3 (en) | Method for preparing bromofluorenes | |
AU3734301A (en) | Method for producing 2-chloro-benzimidazole derivatives | |
AU2001225621A1 (en) | Method for producing nitrogenous-potash fertiliser | |
AU2002212224A1 (en) | Method for producing delta1-pyrrolines | |
AU2002220757A1 (en) | Method for obtaining azaerythromycin | |
AU2001295658A1 (en) | Method for 3d adaptation | |
AU1283001A (en) | Method for producing alkylhalogenosilanes | |
AU2001294449A1 (en) | Method for producing an antineoplastic | |
AU2001262147A1 (en) | Method for producing 4-bromo- and 4-chloro-2-nitro-1-trifluoromethoxybenzene | |
AU2001287723A1 (en) | Method for producing delta 1-pyrrolines | |
AU1141501A (en) | Method for producing hydroxymethylpyridines | |
AU6691600A (en) | Method for producing 4-cyano-2-aminomethylthiazol | |
AU2562001A (en) | Method for producing nitrogenous-potash fertiliser | |
AU2001281953A1 (en) | Method for producing ep(d)m | |
AU2001235423A1 (en) | Method for producing 2,3,5,6-tetrahalogen-xylylidene compounds |